1. 1616 A double blind, self-controlled randomized trial of prophylactic topical vitamin K1 cream application for cetuximab-related skin toxicity (VANQUISH trial). (September 2015) Authors: Tsushima, T.; Yamazaki, K.; Kato, T.; Taku, K.; Yoshida, Y.; Hamauchi, S.; Yoshikawa, S.; Yagi, H.; Kimura, M.; Ishikawa, H.; Kimura, M.; Nakajo, M.; Sakata, S.; Masujima, H.; Miyazawa, A.; Saitou, K.; Izawa, M.; Iwami, K.; Yamanaka, T.; Kiyohara, Y. Journal: European journal of cancer Issue: Volume 51:(2015)Supplement 3 Page Start: S243 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. 394PA self-controlled trial of prophylactic topical application of vitamin K1 cream for cetuximab-related skin rash. (19th December 2015) Authors: Ishikawa, H.; Kato, T.; Yamazaki, K.; Taku, K.; Tsushima, T.; Yoshida, Y.; Hamauchi, S.; Yoshikawa, S.; Yagi, H.; Kimura, M.; Kimura, M.; Nakajo, M.; Sakata, S.; Masujima, H.; Miyazawa, A.; Izawa, M.; Iwami, K.; Yamanaka, T.; Kiyohara, Y. Journal: Annals of oncology Issue: Volume 26(2015)Supplement 9 Page Start: ix118 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗